Clinical evaluation of multiple sclerosis:: quantification by use of scales

被引:6
|
作者
Izquierdo, G [1 ]
Ruiz-Peña, JL [1 ]
机构
[1] Hop Univ Virgen Macarena, Serv Neurol, Unidad Esclerosis, E-41009 Seville, Spain
关键词
clinical evaluation; cognitive impairment; EDSS; fatigue; multiple sclerosis; functional composite; scales;
D O I
10.33588/rn.3602.2002350
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Clinical evaluation is indispensable in multiple sclerosis (MS)for the quantitative measurement of the extent of the disorder, which is in turn required to find out how the disease is evolving and the influence the different forms of treatment are having on it, both in the experimental phase and in the usual monitoring they are subjected to. Method We review the different scales that are used to evaluate the distinct symptomatic and functional aspects of MS and the repercussions these have on the extent of disability displayed in the patient's social and personal life. Although in recent years, the EDSS has been an essential, irreplaceable scale in MS, other instruments of measurement that complement it have also begun to appear. The fatigue, cognitive function and quality of life scales are being used more and more frequently. The Multiple Sclerosis Functional Composite is an instrument that is used more and more frequently in MS and has proved to be highly sensitive in the evaluation of very important clinical trials. Conclusions. The lack of correlation between the distinct scales corroborates the fact that they measure complementary aspects of MS.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [41] USE OF RATING-SCALES TO REFLECT COGNITIVE AND MENTAL FUNCTIONING IN MULTIPLE-SCLEROSIS
    MEDAER, R
    DESMEDT, L
    SWERTS, M
    GEUTJENS, J
    ACTA NEUROLOGICA SCANDINAVICA, 1984, 70 : 65 - 67
  • [42] The Performance Scales disability measure for multiple sclerosis: use and sensitivity to clinically important differences
    Schwartz, Carolyn E.
    Powell, Victoria E.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [43] New outcome measures for multiple sclerosis clinical research: The symptom inventory and the performance scales
    Schwartz, C
    Vollmer, T
    Zeng, Q
    NEUROLOGY, 1996, 46 (02) : 4125 - 4125
  • [44] Impairment disability and handicap scales in multiple sclerosis
    Arbizu-Urdiain, T
    Martínez-Yélamos, A
    Casado-Ruiz, V
    REVISTA DE NEUROLOGIA, 2002, 35 (11) : 1081 - 1093
  • [45] Multiple sclerosis: assessment of disability and disability scales
    A. J. Thompson
    Jeremy C. Hobart
    Journal of Neurology, 1998, 245 : 189 - 196
  • [46] Multiple sclerosis: assessment of disability and disability scales
    Thompson, AJ
    Hobart, JC
    JOURNAL OF NEUROLOGY, 1998, 245 (04) : 189 - 196
  • [47] Use of MRI in Clinical Decision-Making in Multiple Sclerosis
    Kendis, Hallie S.
    Lynn, D. Joanne
    Cross, Anne H.
    Greenberg, Benjamin M.
    Racke, Michael K.
    NEUROLOGY, 2009, 72 (11) : A242 - A242
  • [48] Oral contraceptive use and clinical outcomes in patients with multiple sclerosis
    Sena, Armando
    Couderc, Remy
    Vasconcelos, Joana C.
    Ferret-Sena, Veronique
    Pedrosa, Rui
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 317 (1-2) : 47 - 51
  • [49] Recommendations for the clinical use of motor evoked potentials in multiple sclerosis
    Fernandez, V.
    Valls-Sole, J.
    Relova, J. L.
    Raguer, N.
    Miralles, F.
    Dinca, L.
    Taramundi, S.
    Costa-Frossardo, L.
    Ferrandiz, M.
    Ramio-Torrenta, Ll
    Villoslada, P.
    Saiz, A.
    Callesef, C.
    Antiguedad, A.
    Alvarez-Cermeno, J. C.
    Prieto, J. M.
    Izquierdo, G.
    Montalban, X.
    Fernandez, Y.
    NEUROLOGIA, 2013, 28 (07): : 408 - 416
  • [50] Comparison of brain atrophy measures for clinical use in multiple sclerosis
    Storelli, L.
    Rocca, M. A.
    Pagani, E.
    van Hecke, W.
    de Stefano, N.
    Rovira, A.
    Sastre-Garriga, J.
    Palace, J. A.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 662 - 663